O462 A no-cost breast cancer screening program promotes cervical cancer screening services to an underserved population of women

2009 ◽  
Vol 107 ◽  
pp. S224-S224
Author(s):  
D. Khabele ◽  
M. Egger ◽  
T. Campbell ◽  
M. Dewey ◽  
M. Overlock ◽  
...  
2018 ◽  
Vol 4 (Supplement 2) ◽  
pp. 213s-213s ◽  
Author(s):  
H.T. Kolo

Background: Prevalence of breast and cervical cancer are on the increase in the developing countries despite the knowledge of how these diseases can be prevented through screening. Reproductive rights, Advocacy, Safe space and Empowerment Foundation (RAISE) initiated breast and cervical cancer screening program in Niger State as part of its reproductive health services. The program is hereby evaluated with the aim of improving its performance toward reducing burden of these diseases in Niger State. Aim: To evaluate the breast and cervical cancer screening program, to report the experience from the program, and to recommend necessary changes and scaling up of best practices. Methods: Audit of the breast and cervical cancer screening program was conducted. The basic components of cervical cancer screening programs; screening uptake, screening services, treatment of screen positives, follow-up and referrals were audited against previously set standards for the program. The difference in screening uptake for breast and cervical cancer was evaluated for better understanding of factors determining screening uptake in Niger state. Results: Between 18 July 2016 and 30 April 2018, 2035 women between the age of 15-75 years were screened for breast cancer and 1258 women between the age of 20-55 years were screened for cervical cancer, representing about 38% higher uptake of breast cancer screening compared with cervical cancer. The parity range of these women is 0-20. The mean age and parity for women screened during the audit period were; 35 years and 8 for breast cancer, while 29 years and 7 for cervical cancer. Fifty-two (2.56%) of the 2035 women screened for breast cancer had a palpable lump in either 1 or both breasts, while 4 (0.3%) of the 1258 women screened for cervical cancer had a positive result (aceto-white lesions) treated with cryotherapy. The women have low socioeconomic status with predominantly farmers, petty traders and housewives earning less than $2 per day. Most of the women are illiterate with little or no form of education. Other possible barriers for low uptake of breast and cervical cancer screening is lack of transportation, religious and cultural beliefs, shyness and lack of sensitization. Conclusion: Screening uptake is still very poor despite massive awareness campaign. The current awareness creation strategy has not been able to create needed demand for the available screening services. A total overhaul of awareness creation strategies is therefore advocated.


2018 ◽  
Vol 4 (Supplement 2) ◽  
pp. 51s-51s
Author(s):  
M. Wahidin

Background: Cervical and breast cancer screening have been national program in Indonesia since 2007. The Ministry of Health of Indonesia in collaboration with provincial and district government developed and implemented the program. Method of cervical cancer screening was visual inspection with acetic acid (VIA) or Papanicolaou test and early treatment with cryotherapy for VIA positive. Meanwhile, method of breast cancer screening was clinical breast examination (CBE). After 10 years of implementation, it need to know how the program was conducted and what the results are. Aim: The study was aimed to know activities and results of cervical and breast cancer screening in 10 years (2007-2016). Methods: Design of the study was descriptive study through literature and data review from related data and information sources. Secondary data were collected from Directorate of Non Communicable Disease Control, Ministry of Health, Directorate of Primary Health Service, and professionals. The study was conducted in November-December 2017. Results: Program of cervical and breast cancer screening was started by pilot project in 2007 by 6 districts of 6 provinces in Indonesia: Jakarta, West Java, Central Java, Jogjakarta, North Sumatera, and South Sulawesi. By April 21, 2008 the program was launched as national program by Indonesian First Lady. Then, the program was developed in all province in Indonesia. Activities conducted to develop the program were training of trainers at national level, trainings at district level, socialization to community, providing services of the screening, monitoring, and evaluation. The screening was provided by trained health care provider (general practitioner and midwife) in primary health centers with referral system to district/municipality hospitals. Target of the program was women aged 30-50 years. Since 2007 till 2016, the program was running in all 34 (100%) provinces, 393 out of 514 districts/municipalities (76%), 3706 out of 9813 primary health centers (38%). Clinical trainers of the program were 366 persons consists of OB/GYN oncologist, OB/GYN surgeon oncologist, surgeon, general practitioners, and midwives. Providers of screening were 8526 persons consists of 2783 general practitioners, and 5743 midwives (2.3 providers per primary health center). There were 375 cryotherapy set for early treatment of VIA positive. The result of ten years cervical and breast cancer screening showed that 1,925,943 women have been screened or 5.15% of target 37.4 million women. It was still lower than target of 20% in 2016. VIA positive 73,453 women (3.8%), suspect of cervical cancer 1739 (1 per 1000), lump/tumor in the breast 4030 women (2.1 per 1000). Conclusion: Cervical and breast cancer screening program was running in all provinces and majority of district/municipalities in Indonesia with adequate human resources, but the coverage of the screening was still low.


2008 ◽  
Vol 149 (32) ◽  
pp. 1491-1498 ◽  
Author(s):  
Imre Boncz ◽  
Andor Sebestyén ◽  
Lajos Döbrőssy ◽  
Zoltán Péntek ◽  
Attila Kovács ◽  
...  

Célkitűzés: Az országos kiterjedésű, szervezett emlőszűrési program 2002 januárjában indult el Magyarországon a 45–65 év közötti nők számára 2 éves szűrési intervallummal. A dolgozat célja a szervezett emlőszűrési program részvételi mutatóinak meghatározása, beleértve a szűrési és diagnosztikus célú képalkotó emlőfelvételek gyakoriságának elemzését. Adatok és módszerek: Az elemzésben szereplő adatok az Országos Egészségbiztosítási Pénztár finanszírozási adatbázisából származnak, és a 2000–2005 közötti 6 évet ölelik fel. A 45–65 éves nők körében meghatározták azok arányát, akik a szervezett szűrést megelőző két évben (2000–2001), illetve a program első két ciklusában (2002–2003, 2004–2005) akár szűrési, akár diagnosztikai célú képalkotó emlővizsgálaton vettek részt. Eredmények: A szűrési célú képalkotó emlőfelvételen részt vettek aránya (átszűrtség) a 2000–2001-es 7,4%-ról a 2002–2003-as, illetve 2004–2005-ös szervezett emlőszűrési ciklusban 34,0, illetve 29,5%-ra emelkedett. A diagnosztikus célú képalkotó emlőfelvételen részt vettek aránya (átvizsgáltság) pedig ugyanezen időszakokban 19,8%-ról 22,1 (2002–2003), illetve 23,2%-ra (2004–2005) emelkedett. Az országos lefedettség (átszűrtség + átvizsgáltság) ennek megfelelően a szervezett szűrés hatására 26,2%-ról (2000–2001) 53,5%-ra (2002–2003), illetve 50,8%-ra (2004–2005) nőtt a vizsgált kétéves ciklusban a 45–65 év közötti nők esetében. Következtetés: A magyar emlőszűrési program kezdeti részvételi arányai 2004–2005-ben kissé csökkentek; az emlőrák miatti halálozás érdemi csökkentéséhez ennek emelése szükséges.


QJM ◽  
2021 ◽  
Vol 114 (Supplement_1) ◽  
Author(s):  
Ghada Khaled Ahmed ◽  
Mounir Sobhy Guirguis ◽  
Mona Gamalluldin Alsayed Alkaphoury

Abstract Background Breast cancer remains one of the leading causes of death in women over the age of 40 years. Breast cancer screening is used to identify women with asymptomatic cancer with the goal of enabling women to undergo less invasive treatments that lead to better outcomes, ideally at earlier stages and before the cancer progresses. Mammography is the best-studied breast cancer screening modality and the only recommended imaging tool for screening the general population of women. Objective to correlate the relation between ACR density of breast and breast cancer in screening program. Patients and Methods Our study included 40 women of breast cancer were depicted radiologically and histo-pathologically diagnosed after outreaching for screening by Digital Mammography by the Egyptian National Breast Cancer Screening Program in Ain Shams University Hospitals at period from January 2018 to October 2019.Their data were collected from the medical records of the program. Their age ranged between 40 and 65 years. Results According to the BI-RADS 5th edition 2013, cases were classified into four classes as follows: 6 were ACR-A (15.0%), 21 were ACR-B (52.5%), 12 were ACR-C (30.0%) and 1 were ACR-D (2.5%), So according to our study results dense breast shouldn’t be considered as a risk factor for breast cancer as we observed that the percentage of breast cancer in our study increases the most with average breast density ACR class B then increases with ACR class C and A respectively. Conclusion dense breast is not a risk factor for breast cancer, so further researches are needed to study the relationship between breast density and breast cancer in Egyptian population, to elucidate the role of breast density estimation in prediction of breast cancer considering the genotypical and phenotypical differences of the Egyptian population.


Sign in / Sign up

Export Citation Format

Share Document